These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 7150461)

  • 1. Oral piretanide in chronic renal failure.
    Henderson IS; Beattie TJ; Kennedy AC; Dombey SL
    Br J Clin Pharmacol; 1982 Dec; 14(6):857-60. PubMed ID: 7150461
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of piretanide, bumetanide and frusemide on electrolyte and urate excretion in normal subjects.
    Roberts CJ; Homeida M; Roberts F; Bogie W
    Br J Clin Pharmacol; 1978 Aug; 6(2):129-33. PubMed ID: 678389
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acute effect of high dose (48 mg) of piretanide in advanced renal insufficiency.
    Hadj Aissa A; Pozet N; Labeeuw M; Pellet M; Traeger J
    Br J Clin Pharmacol; 1981 Jan; 11(1):63-8. PubMed ID: 7213511
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Clinical comparative trial of piretanide and furosemide in patients with advanced renal insufficiency. Drug levels and diuretic potency of single oral doses].
    Heuer LJ; Machnik H; Studt J; Fink R
    Arzneimittelforschung; 1983; 33(9):1318-21. PubMed ID: 6685516
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Bumetanide, a new diuretic active during chronic renal failure (author's transl)].
    Fries D; Beroniade V; Coy JL; Delavelle F
    Pathol Biol (Paris); 1976 Jun; 24(6):435-9. PubMed ID: 785349
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A single dose comparison of piretanide and bumetanide in congestive cardiac failure.
    Homeida M; Roberts CJ; Dombey SL
    Br J Clin Pharmacol; 1979 Aug; 8(2):173-8. PubMed ID: 385025
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of the short-term effects of the loop diuretic piretanide and furosemide in patients with renal insufficiency.
    Marone C; Reubi FC; Lahn W
    Eur J Clin Pharmacol; 1984; 26(4):413-8. PubMed ID: 6734705
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Renal actions of piretanide and three other "loop" diuretics.
    McNabb WR; Noormohamed FH; Brooks BA; Lant AF
    Clin Pharmacol Ther; 1984 Mar; 35(3):328-37. PubMed ID: 6697640
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diuretic action of bumetanide in advanced chronic renal insufficiency.
    Berg KJ; Tromsdal A; Wideroe TE
    Eur J Clin Pharmacol; 1976 Feb; 9(4):265-75. PubMed ID: 786692
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Bumetanide in renal insufficiency].
    Humair L
    Schweiz Med Wochenschr; 1982 Feb; 112(9):310-4. PubMed ID: 7079713
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanisms of reduced effects of loop diuretics in healthy volunteers and in patients with renal disease.
    Sjöström P
    Scand J Urol Nephrol Suppl; 1988; 111():1-66. PubMed ID: 3201162
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Piretanide: a loop-active diuretic. Pharmacology, therapeutic efficacy and adverse effects.
    Marsh JD; Smith TW
    Pharmacotherapy; 1984; 4(4):170-80. PubMed ID: 6384944
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acute and long-term renal and metabolic effects of piretanide in congestive cardiac failure.
    McNabb WR; Noormohamed FH; Lant AF
    Br J Clin Pharmacol; 1988 Aug; 26(2):143-54. PubMed ID: 3207551
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of a new diuretic (piretanide) compared with furosemide on renal diluting and concentrating mechanisms in patients with the nephrotic syndrome.
    Marone C; Reubi FC
    Eur J Clin Pharmacol; 1980; 17(3):165-71. PubMed ID: 7363930
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Constant K+/Na+ excretion ratio during peak diuresis after piretanide but insignificant K+ loss during 24 hours.
    Knauf H; Mutschler E
    Eur J Clin Pharmacol; 1992; 43(1):23-7. PubMed ID: 1505604
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Piretanide. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy.
    Clissold SP; Brogden RN
    Drugs; 1985 Jun; 29(6):489-530. PubMed ID: 3891305
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activity of a new high efficiency diuretic in man: piretanide (HOE 118).
    Pozet N; Hadj-Aissa A; Pellet M; Traeger J
    Br J Clin Pharmacol; 1980 Jun; 9(6):577-83. PubMed ID: 7387813
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The efficacy of diuretics in acute and chronic renal failure. Focus on torasemide.
    Risler T; Krämer B; Müller GA
    Drugs; 1991; 41 Suppl 3():69-79. PubMed ID: 1712716
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of loop diuretics in patients with chronic renal insufficiency.
    Voelker JR; Cartwright-Brown D; Anderson S; Leinfelder J; Sica DA; Kokko JP; Brater DC
    Kidney Int; 1987 Oct; 32(4):572-8. PubMed ID: 3430953
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oral bumetanide in chronic renal failure.
    Allison ME; Lindsay MK; Kennedy AC
    Postgrad Med J; 1975; 51 Suppl 6():47-50. PubMed ID: 1105533
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.